Pharmaceutical Industry Reports Rivaroxaban market Zum Anzeigen klicken
  • Kommentare

Pharmaceutical Industry Reports

Rivaroxaban market

Veröffentlicht am in "Gesundheit & Fitness, Wissenschaft", Sprache — English. 8 Seiten.
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Mehr anzeigen

Andere Publikationen von "Pharmaceutical Industry Reports"

Alle Publikationen anzeigen